Surphage

1 known investors

Surphage develops specific bacteriophage combinations (branded NeoPhage) to control pathogenic bacteria such as Salmonella, Escherichia coli, and Listeria monocytogenes in animal and plant production without the use of antibiotics. Its powdered, easy-to-apply antimicrobial products serve the livestock, agriculture, and food-processing industries.

AgTechBiotechFoodTech